Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Psycho-Oncology|November 17, 2019
A Qualitative Study of Smoking-Related Causal Attributions and Risk Perceptions in Cervical Cancer SurvivorsGabriella E Puleo, Tia N Borger, Devin Montgomery, et al.
Journal of Medicinal Chemistry|February 21, 2015
Structure-based evaluation of non-nucleoside inhibitors with improved potency and solubility that target HIV reverse transcriptase variantsKathleen M Frey, David E Puleo, Krasimir A Spasov, et al.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|March 25, 2021
A descriptive study of cervical cancer survivors' persistent smoking behavior and perceived barriers to quittingTia N Borger, Gabriella E Puleo, Jessica N Rivera Rivera, et al.
The American Journal of Clinical Nutrition|July 11, 1992
Effects of alterations in fatty acid intake on the blood pressure of adolescents: the Exeter-Andover ProjectR J Goldberg, R C Ellison, D W Hosmer, et al.
ACS Medicinal Chemistry Letters|June 20, 2017
JAK2 JH2 Fluorescence Polarization Assay and Crystal Structures for Complexes with Three Small MoleculesAna S Newton, Luca Deiana, David E Puleo, et al.
Medicine and Science in Sports and Exercise|May 1, 1995
Chronic psychological effects of exercise and exercise plus cognitive strategiesD R Brown, Y Wang, A Ward, et al.
ACS Medicinal Chemistry Letters|June 20, 2017
Identification and Characterization of JAK2 Pseudokinase Domain Small Molecule BindersDavid E Puleo, Kaury Kucera, Henrik M Hammarén, et al.
Journal of Medicinal Chemistry|April 25, 2020
Selective Janus Kinase 2 (JAK2) Pseudokinase Ligands with a Diaminotriazole CoreMaria-Elena Liosi, Stefan G Krimmer, Ana S Newton, et al.
Tetrahedron Letters|August 16, 2021
Indoloxytriazines as binding molecules for the JAK2 JH2 pseudokinase domain and its V617F variantAna S Newton, Maria-Elena Liosi, Sean P Henry, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2018
Identification of a biologically active fragment of ALK and LTK-Ligand 2 (augmentor-α)Andrey V Reshetnyak, Jyotidarsini Mohanty, Francisco Tomé, et al.
Pageof 3